 Patients will receive Rituximab, Bortezomib, cyclophosphamide, Doxorubicin, Vincristine, Dexamethasone in three week intervals for 6 cycles; then rituximab consolidation weekly x 4 , then one dose of rituximab every 12 weeks until 5 years or disease progression. 